Streetbeat News

Analyst Ratings

TFII

Stephens & Co. has downgraded TFI International from Overweight to Equal-Weight and reduced its price target from $176 to $149.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:22 pm

BTSG

Guggenheim has maintained its Buy rating on BrightSpring Health (NASDAQ:BTSG) and raised the price target from $15 to $18.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:18 pm

SNOW

Snowflake's shares are experiencing a decline following Argus Research's initiation of coverage with a Hold rating.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:17 pm

CMG

Market whales have shown a bullish stance on Chipotle Mexican Grill (NYSE:CMG) with significant options trading activity. Despite a recent price drop, analysts have set a target price of $65.0. The next earnings report is due in 28 days.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 5:16 pm

VEEV

Guggenheim analyst Jack Wallace has maintained a Buy rating on Veeva Systems and raised the price target from $233 to $249.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:15 pm

SLNO

Stifel analyst Dae Gon Ha has maintained a Buy rating on Soleno Therapeutics and raised the price target from $59 to $74.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:14 pm

ANET

Evercore ISI Group has maintained its 'Outperform' rating on Arista Networks and raised the price target from $400 to $425, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:10 pm

MRUS

Guggenheim analyst Michael Schmitz has maintained a Buy rating on Merus (NASDAQ:MRUS) and increased the price target from $93 to $111.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:10 pm

IGMS

Guggenheim has maintained its Buy rating on IGM Biosciences but has lowered the price target from $25 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:07 pm

ZBH

Evercore ISI Group has maintained an 'In-Line' rating on Zimmer Biomet Holdings (NYSE:ZBH) while lowering the price target from $113 to $110.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 5:07 pm